Isis Pharmacuetical association considers to replace its name

The ISIS attack on Paris has come up with many criticisms.  This incident has stirred the whole world and has badly affected the repute of some of the major organizations too.

According to VirmMac, the company is named after an Egyptian enchantress associated with good fitness and health. As people nowadays do not consider the original relation of the name, what they hear is a word "Isis" which is a terrorist group.  This prompts the California biotech organization Isis Pharmaceuticals to change its name to a more acceptable one. 

However, on Monday, Isis Pharmaceuticals claimed to CNNMoney that changing a name is just forethought. No final statement has been given and it's still blurred of new names are being discussed.

"Even yet people know we're not compared with a militant group, a name itself has so many disastrous connotations," pronounced D. Wade Walke, a company's clamp boss for corporate communications and financier relations. "It's apparently not removing improved over time."

In addition, he marked an "awful tragedy" that killed around 129 people in Paris "weighs on us utterly a bit."

According to KCRA, Isis is a medical organization which  manufactures drugs for treating cancer, heart disease and neurological disorders such as ALS, which is also known as Lou Gehrig's disease. Although last year, the company told CNNMoney  that it felt no pressure to change its name or stock ticker symbol, which is "ISIS." It did not consider changing its name previously because it doesn't sell its drugs directly to consumers. Institutional investors had indicated to the company that the name wasn't an issue for them. But now, Walke admits that "subliminally it can't help."

On Monday, shares of Isis dropped 4% despite a broad rally on Wall Street. The pharmaceutical company didn't provide a solid statement on what has caused the down in its stock market. However, the Paris terror attacks, that ISIS have claimed responsibility for is still not clearly linked to the loss, as mentioned by CNN Money. 

According to Walke, the company's stock drop may have been related to Clovis Oncology (CLVS), a rival company that also produce cancer drugs. On Monday, the drug maker's 70% shares dropped sharply after  FDA has requested to acquire more data on  its lead drug candidate, Rociletinib.

Isis Pharmaceutical is fed up of having its name tied or associated with the terrorist group that gave them the consideration for a better name since they are established to heal and make lives better and not to hurt or kill.